Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

Superbugs

Fighting superbugs: 4 recommendations from Consumer Reports

Experts, including the US Centers for Disease Control and Prevention (CDC), World Health Organization and White House, say antibiotics are becoming ineffective because of widespread overuse and misuse, requiring urgent action. Ways to fight back

First-in-class therapy promising for Parkinson's disease psychosis

A first-in-class antipsychotic that is a selective serotonin inverse agonist (with no dopaminergic, histaminergic, adrenergic, or muscarinic activity) potentially targeting 5-HT2A receptors, improved Parkinson's disease psychosis (PDP) with demonstrated safety and tolerability, and without worsening motor Parkinson's, according to data presented at the 19th International Congress of Parkinson's Disease and Movement Disorders. Data details

Continuing Education

MTM essentials for COPD management: Part 1

This month's CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month’s activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT31-KTJ28.

To login to the Online CE Center, go to:
https://web2.uconn.edu/pharmacyce/login.php.
To review your registration page or to register, go to:
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to:
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Pharma needs to be more upfront about FDA drug rejections

When drugs are rejected by FDA, pharma needs to be more transparent about why, according to a study in the British Medical Journal. Details

July 3, 2015

Related Articles

Economist: $37 billion needed to combat “superbugs”

FDA approves generic Comtan tablets for Parkinson's

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA